ILLUMINA INC (ILMN)       214.03  +1.25 (+0.59%)

214.03  +1.25 (+0.59%)

US4523271090 - Common Stock - After market: 214 -0.03 (-0.01%)

ILLUMINA INC214.03

NASDAQ:ILMN (1/27/2023, 7:14:56 PM)+1.25 (+0.59%)

After market: 214 -0.03 (-0.01%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Life Sciences Tools & Services

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-08 2023-02-08
Ins Owners 0.15% Inst Owners 186.53%
Market Cap 33.67B Shares 157.30M
PE 78.4 Fwd PE 68.61
Dividend Yield N/A Analysts 71.2
IPO 06-28 2000-06-28

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ILMN Daily chart

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 9,800 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The firm's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA 92122

P: 18582024500.0

CEO: Francis A. deSouza

Employees: 9800

Website: https://www.illumina.com

ILMN News

News Image3 days ago - Market News VideoILMN March 10th Options Begin TradingNews Image4 days ago - Seeking AlphaIllumina downgraded to hold at Argus on poor near-term outlook (NASDAQ:ILMN)

Argus has downgraded Illumina (ILMN) to hold from buy citing falling margins and worsening outlook.

News Image11 days ago - Seeking AlphaNIH outlays fall, US govt healthcare grants grow but Biopharma financings fall Y/Y

Outlays from the National Institutes of Health ((NIH)) for December 2022 decreased ~4% Y/Y (-35% versus November 2022), according to report from Baird Equity Research.December 2022...

News Image16 days ago - Market News VideoFriday Sector Leaders: Healthcare, ServicesNews Image16 days ago - Investor's Business DailyStock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review

Sharp Tesla price cuts and some notable earnings were in focus.

News Image17 days ago - Market News VideoThursday Sector Laggards: Healthcare, Utilities

ILMN Twits

Here you can normally see the latest stock twits on ILMN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example